Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial.

被引：0
|
作者：
Leibler, C. [1 ]
Canoui, F. [2 ]
Matignon, M. [1 ]
Rondeau, E. [3 ]
Zarour, A. [2 ]
Durrbach, A. [4 ]
Malard, S. [5 ]
Grimbert, P. [1 ]
机构：
[1] APHP Henri Mondor, Nephrol Transplantat, Creteil, France
[2] APHP Henri Mondor, Publ Hlth, Creteil, France
[3] APHP Tenon, Nephrol Transplantat, Paris, France
[4] APHP Bicetre, Nephrol Transplantat, Le Kremlin Bicetre, France
[5] APHP St Louis, Histocompatibil, Paris, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
121
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [21] DONOR SPECIFIC ANTI-HLA ANTIBODIES ARE ASSOCIATED WITH SUBCLINICAL ALLOGRAFT INJURY IN HEART TRANSPLANT RECIPIENTS
    Nagahama, Hugo Kaneku
    Guerrero-Miranda, Cesar Y.
    Masiakos, Peter
    Pullman, James
    Jorde, Ulrich
    Colovai, Adriana
    HUMAN IMMUNOLOGY, 2016, 77 : 91 - 91
  • [22] DEVELOPMENT OF C1Q BINDING DONOR SPECIFIC ANTI-HLA ANTIBODIES IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Colovai, Adriana I.
    Savchik, Christina
    Ramkishun, Dianne
    Solomon, Sonia
    Akalin, Enver
    Hayde, Nicole
    HUMAN IMMUNOLOGY, 2017, 78 : 127 - 127
  • [23] Risk Factors and Consequences of De Novo Anti-HLA Donor Specific Antibodies in Kidney Transplant Recipients: The Force Awakens
    Javaid, B.
    Rosen-Bronson, S.
    Li, D.
    Awwad, M.
    Gilbert, A.
    Ghasemian, S.
    Verbesey, J.
    Abrams, P.
    Grafals, M.
    Fenton, J.
    Cannon, C.
    Rapisura, J.
    Moore, J.
    Cooper, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 411 - 411
  • [24] The Utility of the Pirche-ii Score in Risk-Stratifying Simultaneous Liver-Kidney Transplant Recipients with Preformed Donor-Specific Anti-hla Antibodies
    Abu Jawdeh, B. G.
    Khamash, H.
    Budhiraja, P.
    Jaramillo, A.
    Hacke, K.
    Buras, M.
    Rios, I.
    Akin, D. E.
    Van der Walt, C. S.
    Kodali, L.
    Aqel, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S853 - S854
  • [25] USE OF ECULIZUMAB IN A KIDNEY TRANSPALNT RECEPTOR WITH HIGH LEVELS OF DONOR-SPECIFIC ANTI-HLA PREFORMED ANTIBODIES
    Cicora, Federico
    Roberti, Javier
    Mos, Fernando
    Paz, Marta
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2013, 33 (02): : 92 - 96
  • [26] Clinical Relevance of Preformed Donor-Specific Anti-HLA Antibody in Kidney Transplant Recipients Transplanted in a Program Based on Abdr Unacceptable Mismatches
    Dreige, Y. C.
    Almeida, A. A.
    Nakamura, M.
    de Marco, R.
    Foresto, R. D.
    Tedesco-Silva, H.
    Medina-Pestana, J.
    Requiao-Moura, L. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1138 - S1138
  • [27] Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
    Yagisawa, T.
    Kanzawa, T.
    Unagami, K.
    Furusawa, M.
    Inui, M.
    Ishida, H.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 702 - 702
  • [28] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [29] Preexisting anti-HLA donor-specific antibodies in pediatric renal transplant recipients - A new challenge?
    Weber, Lutz T.
    PEDIATRIC TRANSPLANTATION, 2017, 21 (08)
  • [30] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
12345